menu
    • menu

    Company profile for Cumulus Oncology

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cumulus Oncology, founded by Dr. Clare Wareing in 2017, stands as Europe's first oncology biotech creation studio. The establishment of Cumulus was motivated by the perceived shortcomings of the traditional biotech model. Cumulus companies are strategically managed to reach key value inflection points, with dedicated team members assigned based on the scientific area and development stage of each company. This approach also in...
    Cumulus Oncology, founded by Dr. Clare Wareing in 2017, stands as Europe's first oncology biotech creation studio. The establishment of Cumulus was motivated by the perceived shortcomings of the traditional biotech model. Cumulus companies are strategically managed to reach key value inflection points, with dedicated team members assigned based on the scientific area and development stage of each company. This approach also involves the inclusion of experienced business leaders in biotech fundraising, demonstrating Cumulus Oncology's commitment to innovative and effective strategies in the oncology biotech sector.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cumulus Oncologyunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    80, Edinburgh, Scotland EH3
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cumulusoncology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cumulus-oncology/?originalSubdomain=uk
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cumulus Oncology Bolsters Board & Scientific Advisory Team
    Cumulus Oncology Bolsters Board & Scientific Advisory Team

    16 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/16/3150539/0/en/Cumulus-Oncology-Strengthens-Board-of-Directors-Scientific-Advisory-Team.html

    GLOBENEWSWIRE
    16 Sep 2025
    Share Share
    Cumulus And LeadXpro Hit Milestone In GPR68 Drug Discovery Project
    Cumulus And LeadXpro Hit Milestone In GPR68 Drug Discovery Project

    20 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/20/2932552/0/en/Cumulus-Oncology-and-leadXpro-Achieve-Critical-Milestone-in-GPR68-Drug-Discovery-Project.html

    GLOBENEWSWIRE
    20 Aug 2024
    Share Share
    Cumulus Oncology Appoints Catherine Lewis La Torre to its Board of Directors
    Cumulus Oncology Appoints Catherine Lewis La Torre to its Board of Directors

    10 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/10/2895767/0/en/Cumulus-Oncology-Appoints-Catherine-Lewis-La-Torre-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    10 Jun 2024
    Share Share
    Launch of GIO Therapeutics to develop therapeutics targeting G protein receptors
    Launch of GIO Therapeutics to develop therapeutics targeting G protein receptors

    01 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/01/2821708/0/en/Launch-of-GIO-Therapeutics-founded-by-Cumulus-Oncology-to-develop-therapeutics-targeting-G-protein-coupled-receptors-to-treat-cancer-and-inflammation.html

    GLOBENEWSWIRE
    01 Feb 2024
    Share Share
    Cumulus Oncology raises £9m in seed financing
    Cumulus Oncology raises £9m in seed financing

    08 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/08/2805065/0/en/Cumulus-Oncology-raises-9m-in-seed-financing.html

    GLOBENEWSWIRE
    08 Jan 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search